Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 11,960
-260 (-2.13%)
At close: Jul 20, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 162.01 billion as of July 21, 2026. Its market cap has decreased by -58.18% in one year.
Market Cap
162.01B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
11,960.00
ChartMarket Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 162.01B, an increase of 52.54%. That is a compound annual growth rate of 5.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 162.01B | -7.73% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 231.60B |
| Kangstem Biotech | 213.03B |
| curacle co.,ltd. | 188.54B |
| NIBEC | 169.27B |
| Genome & Company | 163.77B |
| Kanaph Therapeutics | 161.96B |
| Y-Biologics | 153.30B |
| Bio Solution | 152.25B |